Global RNA Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNA Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for RNA Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for RNA Vaccines by Country/Region, 2017, 2022 & 2028

2.2 RNA Vaccines Segment by Type

2.2.1 Individualized Cancer Treatment MRNA Vaccine

2.2.2 Infectious Disease Treatment MRNA Vaccine

2.2.3 Infection Prevention MRNA Vaccine

2.3 RNA Vaccines Sales by Type

2.3.1 Global RNA Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global RNA Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global RNA Vaccines Sale Price by Type (2017-2022)

2.4 RNA Vaccines Segment by Application

2.4.1 Infectious Disease

2.4.2 Cancer

2.4.3 Other

2.5 RNA Vaccines Sales by Application

2.5.1 Global RNA Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global RNA Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global RNA Vaccines Sale Price by Application (2017-2022)

3 Global RNA Vaccines by Company

3.1 Global RNA Vaccines Breakdown Data by Company

3.1.1 Global RNA Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global RNA Vaccines Sales Market Share by Company (2020-2022)

3.2 Global RNA Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global RNA Vaccines Revenue by Company (2020-2022)

3.2.2 Global RNA Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global RNA Vaccines Sale Price by Company

3.4 Key Manufacturers RNA Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers RNA Vaccines Product Location Distribution

3.4.2 Players RNA Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for RNA Vaccines by Geographic Region

4.1 World Historic RNA Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global RNA Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global RNA Vaccines Annual Revenue by Geographic Region

4.2 World Historic RNA Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global RNA Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global RNA Vaccines Annual Revenue by Country/Region

4.3 Americas RNA Vaccines Sales Growth

4.4 APAC RNA Vaccines Sales Growth

4.5 Europe RNA Vaccines Sales Growth

4.6 Middle East & Africa RNA Vaccines Sales Growth

5 Americas

5.1 Americas RNA Vaccines Sales by Country

5.1.1 Americas RNA Vaccines Sales by Country (2017-2022)

5.1.2 Americas RNA Vaccines Revenue by Country (2017-2022)

5.2 Americas RNA Vaccines Sales by Type

5.3 Americas RNA Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNA Vaccines Sales by Region

6.1.1 APAC RNA Vaccines Sales by Region (2017-2022)

6.1.2 APAC RNA Vaccines Revenue by Region (2017-2022)

6.2 APAC RNA Vaccines Sales by Type

6.3 APAC RNA Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe RNA Vaccines by Country

7.1.1 Europe RNA Vaccines Sales by Country (2017-2022)

7.1.2 Europe RNA Vaccines Revenue by Country (2017-2022)

7.2 Europe RNA Vaccines Sales by Type

7.3 Europe RNA Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNA Vaccines by Country

8.1.1 Middle East & Africa RNA Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa RNA Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa RNA Vaccines Sales by Type

8.3 Middle East & Africa RNA Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of RNA Vaccines

10.3 Manufacturing Process Analysis of RNA Vaccines

10.4 Industry Chain Structure of RNA Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 RNA Vaccines Distributors

11.3 RNA Vaccines Customer

12 World Forecast Review for RNA Vaccines by Geographic Region

12.1 Global RNA Vaccines Market Size Forecast by Region

12.1.1 Global RNA Vaccines Forecast by Region (2023-2028)

12.1.2 Global RNA Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global RNA Vaccines Forecast by Type

12.7 Global RNA Vaccines Forecast by Application

13 Key Players Analysis

13.1 Moderna Therapeutics

13.1.1 Moderna Therapeutics Company Information

13.1.2 Moderna Therapeutics RNA Vaccines Product Offered

13.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Moderna Therapeutics Main Business Overview

13.1.5 Moderna Therapeutics Latest Developments

13.2 CureVac

13.2.1 CureVac Company Information

13.2.2 CureVac RNA Vaccines Product Offered

13.2.3 CureVac RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CureVac Main Business Overview

13.2.5 CureVac Latest Developments

13.3 Translate Bio

13.3.1 Translate Bio Company Information

13.3.2 Translate Bio RNA Vaccines Product Offered

13.3.3 Translate Bio RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Translate Bio Main Business Overview

13.3.5 Translate Bio Latest Developments

13.4 BioNTech

13.4.1 BioNTech Company Information

13.4.2 BioNTech RNA Vaccines Product Offered

13.4.3 BioNTech RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BioNTech Main Business Overview

13.4.5 BioNTech Latest Developments

13.5 Sangamo Therapeutics

13.5.1 Sangamo Therapeutics Company Information

13.5.2 Sangamo Therapeutics RNA Vaccines Product Offered

13.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sangamo Therapeutics Main Business Overview

13.5.5 Sangamo Therapeutics Latest Developments

13.6 Argos Therapeutics

13.6.1 Argos Therapeutics Company Information

13.6.2 Argos Therapeutics RNA Vaccines Product Offered

13.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Argos Therapeutics Main Business Overview

13.6.5 Argos Therapeutics Latest Developments

13.7 In-Cell-Art

13.7.1 In-Cell-Art Company Information

13.7.2 In-Cell-Art RNA Vaccines Product Offered

13.7.3 In-Cell-Art RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 In-Cell-Art Main Business Overview

13.7.5 In-Cell-Art Latest Developments

13.8 eTheRNA

13.8.1 eTheRNA Company Information

13.8.2 eTheRNA RNA Vaccines Product Offered

13.8.3 eTheRNA RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 eTheRNA Main Business Overview

13.8.5 eTheRNA Latest Developments

13.9 Ethris

13.9.1 Ethris Company Information

13.9.2 Ethris RNA Vaccines Product Offered

13.9.3 Ethris RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Ethris Main Business Overview

13.9.5 Ethris Latest Developments

13.10 Tiba Biotechnology

13.10.1 Tiba Biotechnology Company Information

13.10.2 Tiba Biotechnology RNA Vaccines Product Offered

13.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Tiba Biotechnology Main Business Overview

13.10.5 Tiba Biotechnology Latest Developments

14 Research Findings and Conclusion

Table 1. RNA Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. RNA Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Individualized Cancer Treatment MRNA Vaccine

Table 4. Major Players of Infectious Disease Treatment MRNA Vaccine

Table 5. Major Players of Infection Prevention MRNA Vaccine

Table 6. Global RNA Vaccines Sales by Type (2017-2022) & (K Doses)

Table 7. Global RNA Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global RNA Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global RNA Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global RNA Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 11. Global RNA Vaccines Sales by Application (2017-2022) & (K Doses)

Table 12. Global RNA Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global RNA Vaccines Revenue by Application (2017-2022)

Table 14. Global RNA Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global RNA Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 16. Global RNA Vaccines Sales by Company (2020-2022) & (K Doses)

Table 17. Global RNA Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global RNA Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global RNA Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global RNA Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 21. Key Manufacturers RNA Vaccines Producing Area Distribution and Sales Area

Table 22. Players RNA Vaccines Products Offered

Table 23. RNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global RNA Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 27. Global RNA Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global RNA Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global RNA Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global RNA Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 31. Global RNA Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global RNA Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global RNA Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas RNA Vaccines Sales by Country (2017-2022) & (K Doses)

Table 35. Americas RNA Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas RNA Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas RNA Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas RNA Vaccines Sales by Type (2017-2022) & (K Doses)

Table 39. Americas RNA Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas RNA Vaccines Sales by Application (2017-2022) & (K Doses)

Table 41. Americas RNA Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC RNA Vaccines Sales by Region (2017-2022) & (K Doses)

Table 43. APAC RNA Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC RNA Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC RNA Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC RNA Vaccines Sales by Type (2017-2022) & (K Doses)

Table 47. APAC RNA Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC RNA Vaccines Sales by Application (2017-2022) & (K Doses)

Table 49. APAC RNA Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe RNA Vaccines Sales by Country (2017-2022) & (K Doses)

Table 51. Europe RNA Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe RNA Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe RNA Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe RNA Vaccines Sales by Type (2017-2022) & (K Doses)

Table 55. Europe RNA Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe RNA Vaccines Sales by Application (2017-2022) & (K Doses)

Table 57. Europe RNA Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa RNA Vaccines Sales by Country (2017-2022) & (K Doses)

Table 59. Middle East & Africa RNA Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa RNA Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa RNA Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa RNA Vaccines Sales by Type (2017-2022) & (K Doses)

Table 63. Middle East & Africa RNA Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa RNA Vaccines Sales by Application (2017-2022) & (K Doses)

Table 65. Middle East & Africa RNA Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of RNA Vaccines

Table 67. Key Market Challenges & Risks of RNA Vaccines

Table 68. Key Industry Trends of RNA Vaccines

Table 69. RNA Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. RNA Vaccines Distributors List

Table 72. RNA Vaccines Customer List

Table 73. Global RNA Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 74. Global RNA Vaccines Sales Market Forecast by Region

Table 75. Global RNA Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global RNA Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas RNA Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 78. Americas RNA Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC RNA Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 80. APAC RNA Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe RNA Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Europe RNA Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa RNA Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Middle East & Africa RNA Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global RNA Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 86. Global RNA Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global RNA Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global RNA Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global RNA Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 90. Global RNA Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global RNA Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global RNA Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Moderna Therapeutics Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Moderna Therapeutics RNA Vaccines Product Offered

Table 95. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 96. Moderna Therapeutics Main Business

Table 97. Moderna Therapeutics Latest Developments

Table 98. CureVac Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. CureVac RNA Vaccines Product Offered

Table 100. CureVac RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 101. CureVac Main Business

Table 102. CureVac Latest Developments

Table 103. Translate Bio Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Translate Bio RNA Vaccines Product Offered

Table 105. Translate Bio RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 106. Translate Bio Main Business

Table 107. Translate Bio Latest Developments

Table 108. BioNTech Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. BioNTech RNA Vaccines Product Offered

Table 110. BioNTech RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 111. BioNTech Main Business

Table 112. BioNTech Latest Developments

Table 113. Sangamo Therapeutics Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Sangamo Therapeutics RNA Vaccines Product Offered

Table 115. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 116. Sangamo Therapeutics Main Business

Table 117. Sangamo Therapeutics Latest Developments

Table 118. Argos Therapeutics Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. Argos Therapeutics RNA Vaccines Product Offered

Table 120. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 121. Argos Therapeutics Main Business

Table 122. Argos Therapeutics Latest Developments

Table 123. In-Cell-Art Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. In-Cell-Art RNA Vaccines Product Offered

Table 125. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 126. In-Cell-Art Main Business

Table 127. In-Cell-Art Latest Developments

Table 128. eTheRNA Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. eTheRNA RNA Vaccines Product Offered

Table 130. eTheRNA RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 131. eTheRNA Main Business

Table 132. eTheRNA Latest Developments

Table 133. Ethris Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Ethris RNA Vaccines Product Offered

Table 135. Ethris RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 136. Ethris Main Business

Table 137. Ethris Latest Developments

Table 138. Tiba Biotechnology Basic Information, RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Tiba Biotechnology RNA Vaccines Product Offered

Table 140. Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 141. Tiba Biotechnology Main Business

Table 142. Tiba Biotechnology Latest Developments

List of Figures

Figure 1. Picture of RNA Vaccines

Figure 2. RNA Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global RNA Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global RNA Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. RNA Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Individualized Cancer Treatment MRNA Vaccine

Figure 10. Product Picture of Infectious Disease Treatment MRNA Vaccine

Figure 11. Product Picture of Infection Prevention MRNA Vaccine

Figure 12. Global RNA Vaccines Sales Market Share by Type in 2021

Figure 13. Global RNA Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. RNA Vaccines Consumed in Infectious Disease

Figure 15. Global RNA Vaccines Market: Infectious Disease (2017-2022) & (K Doses)

Figure 16. RNA Vaccines Consumed in Cancer

Figure 17. Global RNA Vaccines Market: Cancer (2017-2022) & (K Doses)

Figure 18. RNA Vaccines Consumed in Other

Figure 19. Global RNA Vaccines Market: Other (2017-2022) & (K Doses)

Figure 20. Global RNA Vaccines Sales Market Share by Application (2017-2022)

Figure 21. Global RNA Vaccines Revenue Market Share by Application in 2021

Figure 22. RNA Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global RNA Vaccines Revenue Market Share by Company in 2021

Figure 24. Global RNA Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global RNA Vaccines Revenue Market Share by Geographic Region in 2021

Figure 26. Global RNA Vaccines Sales Market Share by Region (2017-2022)

Figure 27. Global RNA Vaccines Revenue Market Share by Country/Region in 2021

Figure 28. Americas RNA Vaccines Sales 2017-2022 (K Doses)

Figure 29. Americas RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. APAC RNA Vaccines Sales 2017-2022 (K Doses)

Figure 31. APAC RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Europe RNA Vaccines Sales 2017-2022 (K Doses)

Figure 33. Europe RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa RNA Vaccines Sales 2017-2022 (K Doses)

Figure 35. Middle East & Africa RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Americas RNA Vaccines Sales Market Share by Country in 2021

Figure 37. Americas RNA Vaccines Revenue Market Share by Country in 2021

Figure 38. United States RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC RNA Vaccines Sales Market Share by Region in 2021

Figure 43. APAC RNA Vaccines Revenue Market Share by Regions in 2021

Figure 44. China RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe RNA Vaccines Sales Market Share by Country in 2021

Figure 51. Europe RNA Vaccines Revenue Market Share by Country in 2021

Figure 52. Germany RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa RNA Vaccines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa RNA Vaccines Revenue Market Share by Country in 2021

Figure 59. Egypt RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of RNA Vaccines in 2021

Figure 65. Manufacturing Process Analysis of RNA Vaccines

Figure 66. Industry Chain Structure of RNA Vaccines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles